Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

COVID-19 vaccine elicits antibody responses in nearly 9 out of 10 people taking immunosuppressants

COVID-19 vaccination elicited antibody responses in nearly nine out of 10 people with weakened immune systems, although their responses were only about one-third as strong as those mounted by healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis.

30 Aug 2021

NYU Tandon describes novel peptide with broad therapeutic potential to combat multiple diseases

NYU Tandon professors Mary Cowman and Jin Ryoun Kim recently published a paper describing a novel peptide with broad therapeutic potential to combat chronic inflammation in multiple diseases.

28 Aug 2021

NIH begins clinical trial to assess extra COVID-19 vaccine dose in people with autoimmune disease

The National Institutes of Health has begun a clinical trial to assess the antibody response to an extra dose of an authorized or approved COVID-19 vaccine in people with autoimmune disease who did not respond to an original COVID-19 vaccine regimen.

27 Aug 2021

MS patients on anti-CD20 therapy have robust T cell responses to SARS-CoV-2 vaccination

Scientists have observed that MS patients exhibit a robust T cell response despite a reduced humoral response to COVID-19 vaccines. Read more here.

27 Aug 2021

Higher intake of specific nutrients linked to lower brain iron and better cognition in older adults

Research conducted at the University of Kentucky College of Medicine suggests that higher intake of specific nutrients is associated with lower brain iron concentration and better cognitive performance in older adults.

26 Aug 2021

Athletes with history of concussions may show subtle and chronic brain changes

A new study suggests athletes with a history of concussion may show more brain injury from a later concussion, particularly in middle regions of the brain that are more susceptible to damage, when compared to athletes with no history of concussion.

26 Aug 2021

Study finds a new line of drugs to stimulate myelin repair in multiple sclerosis

In the nearly 1 million Americans living with multiple sclerosis, the fatty substance that insulates the nerves of the central nervous system—called myelin—is damaged.

24 Aug 2021

Cognitive rehabilitation found to be effective in treating multiple sclerosis-related cognitive dysfunction

In a review of recent literature, a team of researchers from Kessler Foundation conclude that cognitive rehabilitation programs are efficacious in treating multiple sclerosis-related cognitive dysfunction, and urge clinicians to consider this low-cost, low-risk, yet effective treatment approach for their patients.

19 Aug 2021

Study finds a lower rate of stroke among immigrants to Canada than long-term residents

Immigrants to Canada have a 33% lower rate of stroke than long-term residents, according to a study published in the August 18, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.

18 Aug 2021

‘I don’t want to risk my life for a paycheck’: Immunosuppressed people grapple with returning to work

Elizabeth Groenweghe got a kidney transplant 14 years ago. She now takes several medications to prevent her body from rejecting her transplant organ. But these medications also weaken her immune system, putting her at higher risk of becoming seriously ill if she catches covid-19.

13 Aug 2021

Pfizer CEO to public: Just trust us on the covid booster

Pfizer CEO Albert Bourla was confident in June about the ability of his company's vaccine to protect against the highly contagious delta variant, as it marched across the globe and filled U.S. hospitals with patients.

13 Aug 2021

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women’s health

Multiple sclerosis affects around three times as many women as men and is commonly diagnosed between the ages of 20 and 40 years, when many women are focusing on career and family planning.

11 Aug 2021

Existing drug may be effective in treating SARS-CoV-2

Scientists from the University of Chicago have found that the drug masitinib may be effective in treating COVID-19.

2 Aug 2021

People with metabolic syndrome may be at higher risk for second stroke, death

People with larger waistlines, high blood pressure and other risk factors that make up metabolic syndrome may be at higher risk for having a second stroke and even dying than people who do not have metabolic syndrome, according to a meta-analysis published in the July 28, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.

28 Jul 2021

Foods high in flavonoids may lower risk of cognitive decline

A new study shows that people who eat a diet that includes at least half a serving per day of foods high in flavonoids like strawberries, oranges, peppers and apples may have a 20% lower risk of cognitive decline.

28 Jul 2021

Existing drug may be effective in treating COVID-19

A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19.

21 Jul 2021

Analysis: Necessary or not, covid booster shots are probably on the horizon

The drugmaker Pfizer recently announced that vaccinated people are likely to need a booster shot to be effectively protected against new variants of covid-19 and that the company would apply for Food and Drug Administration emergency use authorization for the shot.

21 Jul 2021

World Brain Day 2021: An interview with Professor Alan Thompson

In commemoration of World Brain Day 2021, News-Medical spoke to renowned neurology expert Professor Alan Thompson about his incredible career in brain research.

21 Jul 2021

Targeting Piezo1 protein may be a new and ideal strategy to cure multiple sclerosis

In a new University of California, Irvine-led study, researchers found that a certain protein prevented regulatory T cells (Tregs) from effectively doing their job in controlling the damaging effects of inflammation in a model of multiple sclerosis (MS), a devastating autoimmune disease of the nervous system.

20 Jul 2021

New research may offer clues to why MS patients develop progressive disability

Did you know multiple sclerosis (MS) means multiple scars? New research shows that the brain and spinal cord scars in people with MS may offer clues to why they developprogressive disability but those with related diseases where the immune system attacks the central nervous system do not.

19 Jul 2021

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

COVID-19 vaccine elicits antibody responses in nearly 9 out of 10 people taking immunosuppressants

NYU Tandon describes novel peptide with broad therapeutic potential to combat multiple diseases

NIH begins clinical trial to assess extra COVID-19 vaccine dose in people with autoimmune disease

MS patients on anti-CD20 therapy have robust T cell responses to SARS-CoV-2 vaccination

Higher intake of specific nutrients linked to lower brain iron and better cognition in older adults

Athletes with history of concussions may show subtle and chronic brain changes

Study finds a new line of drugs to stimulate myelin repair in multiple sclerosis

Cognitive rehabilitation found to be effective in treating multiple sclerosis-related cognitive dysfunction

Study finds a lower rate of stroke among immigrants to Canada than long-term residents

‘I don’t want to risk my life for a paycheck’: Immunosuppressed people grapple with returning to work

Pfizer CEO to public: Just trust us on the covid booster

MS Australia partners again with Jean Hailes to spotlight multiple sclerosis and women’s health

Existing drug may be effective in treating SARS-CoV-2

People with metabolic syndrome may be at higher risk for second stroke, death

Foods high in flavonoids may lower risk of cognitive decline

Existing drug may be effective in treating COVID-19

Analysis: Necessary or not, covid booster shots are probably on the horizon

World Brain Day 2021: An interview with Professor Alan Thompson

Targeting Piezo1 protein may be a new and ideal strategy to cure multiple sclerosis

New research may offer clues to why MS patients develop progressive disability

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in